Measuring Drug Hypersensitivity in Pediatric Urticaria
A study on drug hypersensitivity in children with chronic spontaneous urticaria found that only 14 out of 28 suspected cases were confirmed, indicating a prevalence of 5.6%. Beta-lactam antibiotics were the most common confirmed agents, followed by nonsteroidal anti-inflammatory drugs and paracetamol. The findings suggest that drug history should be closely examined in children with chronic spontaneous urticaria.
- ▪The study involved 250 children with chronic spontaneous urticaria from January 2018 to December 2023.
- ▪Among the 28 children suspected of drug hypersensitivity, 14 were confirmed through diagnostic evaluation.
- ▪Beta-lactam antibiotics accounted for over half of the confirmed cases of drug hypersensitivity.
Medscape files mainly under health. We currently carry 231 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Medscape |
| Canonical URL | https://www.medscape.com/viewarticle/diagnostic-testing-clarifies-drug-hypersensitivity-pediatric-2026a1000he7?src=rss |
| Publication time | Wed, 27 May 2026 04:29:39 EDT |
| Retrieval time | 2026-05-27T08:37:56.893Z |
| Last seen | 2026-05-27T08:37:56.893Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | i5-queAApU0Q |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
TOPLINE:Drug hypersensitivity (DHS) was suspected in 28 of 250 children with chronic spontaneous urticaria (CSU), but diagnostic testing confirmed true hypersensitivity in only 14 cases, corresponding to an overall prevalence of 5.6%. Beta-lactam antibiotics were the leading confirmed agents, accounting for more than half of the confirmed cases, followed by nonsteroidal anti-inflammatory drugs and paracetamol.METHODOLOGY:Researchers conducted a nested case-control study at a tertiary referral center in Istanbul, Turkey, involving 250 children with CSU followed between January 2018 and December 2023.A total of 28 children (11.2%; 95% CI, 7.9%-15.7%) were identified as having suspected DHS based on structured clinical assessment guided by the European Network for Drug Allergy/Global Allergy…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Medscape.
Discussion
0 commentsMore from Medscape
